Discover
IMA
ImageneBio, Inc.
5.02
2 x 3.61
2 x 6.46
bid
ask
-
0.08
1.57%
2 @ 04:10 PM
5.02 +0.00 (0.00%)
| Ytd | -27.25% | |
| 1y | -62.54% |
4.96
day range
5.16
3.94
52 week range
13.98
| Open | 5.16 | Prev Close | 5.10 | Low | 4.96 | High | 5.16 | Mkt Cap | 57.10M |
| Vol | 12.46K | Avg Vol | 11.49K | EPS | -4.73 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.76 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 5.75 | 200-d Avg | 6.11 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 11.78M | ||
| Research and Development Expense | 6.67M | ||
| Selling, General and Administrative Expense | 5.12M | ||
| Operating Income | -11.78M | ||
| Interest Expense | -1.25M | ||
| Income Tax Expense | 16.00K | ||
| Net Income | -10.18M | ||
| Net Income Common Stock | -10.18M | ||
| Net Income Common Stock (USD) | -10.18M | ||
| Consolidated Income | -10.18M | ||
| Earnings per Basic Share | -0.63 | ||
| Earnings per Basic Share (USD) | -0.63 | ||
| Earnings per Diluted Share | -0.63 | ||
| Earning Before Interest & Taxes (EBIT) | -11.41M | ||
| Earning Before Interest & Taxes (USD) | -11.41M | ||
| Weighted Average Shares | 16.16M | ||
| Weighted Average Shares Diluted | 16.16M | ||
| Balance Sheet | |||
| Cash and Equivalents | 94.68M | ||
| Cash and Equivalents (USD) | 94.68M | ||
| Investments | 44.04M | ||
| Investments Current | 41.48M | ||
| Investments Non-Current | 2.56M | ||
| Current Assets | 141.11M | ||
| Property, Plant & Equipment Net | 521.00K | ||
| Total Assets | 152.04M | ||
| Debt Current | 1.91M | ||
| Total Debt | 1.91M | ||
| Current Liabilities | 6.57M | ||
| Total Liabilities | 9.97M | ||
| Accumulated Retained Earnings (Deficit) | -250.85M | ||
| Accumulated Other Comprehensive Income | -51.00K | ||
| Shareholders Equity | 142.07M | ||
| Shareholders Equity (USD) | 142.07M | ||
| Assets Non-Current | 10.93M | ||
| Total Debt (USD) | 1.91M | ||
| Liabilities Non-Current | 3.40M | ||
| Trade and Non-Trade Payables | 977.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 176.00K | ||
| Net Cash Flow from Financing | 28.05M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 18.63M | ||
| Issuance (Purchase) of Equity Shares | 28.05M | ||
| Net Cash Flow from Investing | -346.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -346.00K | ||
| Net Cash Flow from Operations | -9.07M | ||
| Share Based Compensation | 911.00K | ||